Cellcyte Genetics Corp. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Cellcyte Genetics Corp. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of -$12.78 million as of 2014-09-30, per its 10-Q filed 2014-11-19.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2014-11-19
- 2014-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) -$12.78M.
- 2014-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) -$12.75M.
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) -$12.72M.
- 2013-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) -$12.69M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed |
|---|---|---|
| 2014-09-30 | -$12.78M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | -$12.75M 10-Q · filed 2014-08-19 | |
| 2014-03-31 | -$12.72M 10-Q · filed 2014-05-16 | |
| 2013-12-31 | -$12.69M 10-Q · filed 2014-11-19 | |
| 2013-09-30 | -$12.64M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$12.61M 10-Q · filed 2013-08-19 | |
| 2013-03-31 | -$12.69M 10-Q · filed 2014-05-16 | -$12.56M 10-Q · filed 2013-05-15 |
| 2012-12-31 | -$12.52M 10-K · filed 2014-04-15 | |
| 2012-09-30 | -$12.52M 10-Q · filed 2013-11-14 | -$13.05M 10-Q · filed 2012-11-14 |
| 2012-06-30 | -$13.01M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$13.14M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$13.11M 10-K · filed 2013-04-12 | |
| 2011-09-30 | -$12.90M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | -$12.86M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$12.75M 10-K · filed 2012-04-16 |